Active Epstein-barr Virus Infection
📧 Sign up to get email alerts when something new happens for Active Epstein-barr Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Genetic Studies of Chronic Active Epstein-Barr Disease
This clinical trial update details genetic studies investigating Chronic Active Epstein-Barr virus infection, sponsored by NIAID, which is c…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders [Phase 2]
This Phase 2 clinical trial investigates unrelated cord blood transplantation for Epstein-Barr virus–associated lymphoproliferative diseases…
-
CLINICAL_TRIALS other · 2026-01-27Clinical Trial Update: Golidocitinib Combined With Selinexor for CAEBVD [Phase 2, Phase 3]
A phase 2/phase 3 clinical trial evaluating golidocitinib in combination with selinexor for chronic active Epstein-Barr virus disease is cur…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases [Phase 1]
A Phase 1 clinical trial update for a Therapeutic Immunological Agent targeting EBV-related lymphoproliferative diseases, with the study cur…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT [NA]
This ClinicalTrials.gov entry describes a study evaluating the efficacy and safety of iNK cells for chronic active Epstein-Barr virus infect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: Rituximab Monotherapy for EBV-HLH and CAEBV [Phase 3]
Phase 3 trial update on rituximab monotherapy for EBV-associated conditions, including Secondary Hemophagocytic Lymphohistiocytosis and Chro…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Selinexol Combined With Dexamethasone in the Treatment of CAEBV [Phase 3]
Phase 3 trial update for Selinexol combined with Dexamethasone in chronic active Epstein-Barr virus infection (CAEBV) is ongoing with status…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) [Phase 2]
Phase 2 trial update for reduced intensity conditioning in hemophagocytic syndromes and selected primary immune deficiencies completed with …